WNT3A was up-regulated in GC 35, prostate cancer cells 36, breast cancer 37, 38, which was also up-regulated in oral squamous cell carcinoma and glioma stem cells compared with control nonmalignant tissues 39, 40. This evidence concerns the gene WNT3A and central nervous system cancer.